US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 40.110
  • +0.190+0.48%
Close May 13 16:00 ET
  • 40.110
  • 0.0000.00%
Post 16:10 ET
2.64BMarket Cap-14024P/E (TTM)

About Celldex Therapeutics Company

Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Company Profile

SymbolCLDX
Company NameCelldex Therapeutics
Listing DateMay 1, 1986
Founded1983
CEOMr. Anthony S. Marucci
MarketNASDAQ
Employees160
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressPerryville III Building,53 Frontage Road,Suite 220
CityHampton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08827
Phone1-908-454-7120
Websitehttp://www.celldex.com

Company Executives

  • Name
  • Position
  • Salary
  • Anthony S. Marucci
  • Director, President and Chief Executive Officer
  • 8.36M
  • Elizabeth Crowley
  • Senior Vice President and Chief Product Development Officer
  • --
  • Sam Martin
  • Treasurer, Senior Vice President, Secretary, Principal Accounting Officer and Chief Financial Officer
  • 2.95M
  • Richard M. Wright, PhD
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. Ronald A. Pepin, PhD
  • Senior Vice President and Chief Business Officer
  • --
  • Dr. Tibor Keler, PhD
  • Executive Vice President and Chief Scientific Officer
  • 3.42M
  • Dr. Diane C. Young, M.D.
  • Senior Vice President and Chief Medical Officer
  • 2.97M
  • Freddy A. Jimenez
  • Senior Vice President and General Counsel
  • --
  • Sarah Cavanaugh
  • Senior Vice President, Corporate Affairs and Administration
  • --
  • Dr. Margo Heath-Chiozzi, M.D.
  • Senior Vice President, Regulatory Affairs
  • 2.94M
  • Karen L. Shoos
  • Chairman of the Board
  • 385.77K
  • James J. Marino, J.D.,M.B.A.
  • Independent Director
  • 377.44K
  • Harry H. Penner, Jr
  • Independent Director
  • 371.19K
  • Herbert J. Conrad
  • Independent Director
  • 364.94K
  • Dr. Rita I. Jain, M.D.
  • Independent Director
  • 599.50K
  • Cheryl L. Cohen
  • Independent Director
  • 367.02K
  • Keith L. Brownlie
  • Independent Director
  • 373.27K
  • Herbert J. Conrad
  • Independent Director
  • --
  • Dr. Garry A. Neil, M.D.
  • Independent Director
  • 366.22K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg